What is the correct way to manage anti-IgE treatment
during the COVID-19 pandemic?
Anti-IgE treatment with omalizumab (or other biologics indicated for
asthma) should be continued in non-infected patients.
Self-administration devices at home, whenever this option is available,
are preferred, to minimize face-to-face contact in the clinic. In
infected patients, omalizumab administration should be delayed until
complete clinical recovery and viral clearance is
achieved.44,138